Entia Biosciences
Biotechnology ResearchWashington, United States11-50 Employees
Entia Biosciences, inc. Is a world leader in whole food nutaceuticals research and development. Specializing in vitamin D and LErgothioneine, Entia produces ErgoD2.
Specialized Product Focus Entia Biosciences specializes in whole food nutraceuticals, including vitamin D and L-Ergothioneine, positioning it to appeal to health-conscious consumers and supplement retailers seeking innovative and scientifically supported products.
Growing Revenue Potential With a revenue range of 1 million to 10 million dollars and recent funding of 1.5 million dollars, the company presents opportunities for partnerships and distribution deals to accelerate product development and market reach.
Niche Market Position Operating with a small team of 11 to 50 employees in the biotechnology sector, Entia can be targeted for strategic collaborations that leverage its cutting-edge research capabilities in the nutraceutical space.
Innovation and Research As a leader in nutraceutical research focusing on vitamin D and ergothioneine, there is a strong opportunity to partner on new supplement formulations, clinical research projects, and product validation to enhance market credibility.
Digital Presence and Technology Utilizing advanced web technologies like WordPress, Cloudflare CDN, and LiteSpeed, the company emphasizes online engagement and infrastructure, indicating potential for digital marketing solutions and e-commerce expansion to boost sales channels.
Entia Biosciences uses 8 technology products and services including LiteSpeed Cache, Cloudflare CDN, WordPress, and more. Explore Entia Biosciences's tech stack below.
| Entia Biosciences Email Formats | Percentage |
| First_Last@entiabio.com | 50% |
| First.Last@entiabio.com | 25% |
| FLast@entiabio.com | 25% |
Biotechnology ResearchWashington, United States11-50 Employees
Entia Biosciences, inc. Is a world leader in whole food nutaceuticals research and development. Specializing in vitamin D and LErgothioneine, Entia produces ErgoD2.
Entia Biosciences has raised a total of $1.5M of funding over 1 rounds. Their latest funding round was raised on Nov 14, 2013 in the amount of $1.5M.
Entia Biosciences's revenue is estimated to be in the range of $1M$10M
Entia Biosciences has raised a total of $1.5M of funding over 1 rounds. Their latest funding round was raised on Nov 14, 2013 in the amount of $1.5M.
Entia Biosciences's revenue is estimated to be in the range of $1M$10M